Вінкристин (Ukrainian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Вінкристин" in Ukrainian language version.

refsWebsite

Global rank Ukrainian rank

1^st place

4^th place

5^th place

2^nd place

4^th place

low place

5,119^th place

719^th place

441^st place

399^th place

754^th place

3^rd place

11^th place

11^th place

964^th place

books.google.com

Ravina E (2011). The evolution of drug discovery : from traditional medicines to modern drugs (вид. 1. Aufl.). Weinheim: Wiley-VCH. с. 157—159. ISBN 9783527326693. Архів оригіналу за 1 серпня 2017.

Jordan MA (January 2002). Mechanism of action of antitumor drugs that interact with microtubules and tubulin. Current Medicinal Chemistry. Anti-Cancer Agents. 2 (1): 1—17. doi:10.2174/1568011023354290. PMID 12678749.
Silverman JA, Deitcher SR (March 2013). Marqibo (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine. Cancer Chemotherapy and Pharmacology. 71 (3): 555—64. doi:10.1007/s00280-012-2042-4. PMC 3579462. PMID 23212117.
Morris PG, Fornier MN (November 2008). Microtubule active agents: beyond the taxane frontier. Clinical Cancer Research. 14 (22): 7167—72. doi:10.1158/1078-0432.ccr-08-0169. PMID 19010832. S2CID 2129170.

Vincristine Sulfate. The American Society of Health-System Pharmacists. Архів оригіналу за 2 січня 2015. Процитовано Jan 2, 2015.

Brayfield A, ред. (13 December 2013). Vincristine. Martindale: The Complete Drug Reference. Pharmaceutical Press. Архів оригіналу за 8 April 2020. Процитовано 15 April 2014.

Oncovin, Vincasar PFS (vincristine) dosing, indications, interactions, adverse effects, and more. Medscape Reference. WebMD. Архів оригіналу за 16 April 2014. Процитовано 16 April 2014.

Jordan MA (January 2002). Mechanism of action of antitumor drugs that interact with microtubules and tubulin. Current Medicinal Chemistry. Anti-Cancer Agents. 2 (1): 1—17. doi:10.2174/1568011023354290. PMID 12678749.
Silverman JA, Deitcher SR (March 2013). Marqibo (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine. Cancer Chemotherapy and Pharmacology. 71 (3): 555—64. doi:10.1007/s00280-012-2042-4. PMC 3579462. PMID 23212117.
Morris PG, Fornier MN (November 2008). Microtubule active agents: beyond the taxane frontier. Clinical Cancer Research. 14 (22): 7167—72. doi:10.1158/1078-0432.ccr-08-0169. PMID 19010832. S2CID 2129170.

Morris PG, Fornier MN (November 2008). Microtubule active agents: beyond the taxane frontier. Clinical Cancer Research. 14 (22): 7167—72. doi:10.1158/1078-0432.ccr-08-0169. PMID 19010832. S2CID 2129170.

Brayfield A, ред. (13 December 2013). Vincristine. Martindale: The Complete Drug Reference. Pharmaceutical Press. Архів оригіналу за 8 April 2020. Процитовано 15 April 2014.
Oncovin, Vincasar PFS (vincristine) dosing, indications, interactions, adverse effects, and more. Medscape Reference. WebMD. Архів оригіналу за 16 April 2014. Процитовано 16 April 2014.
Vincristine Sulfate. The American Society of Health-System Pharmacists. Архів оригіналу за 2 січня 2015. Процитовано Jan 2, 2015.
Ravina E (2011). The evolution of drug discovery : from traditional medicines to modern drugs (вид. 1. Aufl.). Weinheim: Wiley-VCH. с. 157—159. ISBN 9783527326693. Архів оригіналу за 1 серпня 2017.